Dr. Beverly Ann Reader, MD

Dr. Reader practices at GeneX Laboratories - Costa Mesa in Costa Mesa, California.

Dr. Reader's NPI, 1396937868, was assigned on August 17, 2007. Dr. Reader graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2005. Dr. Reader holds California license A112747.

Dr. Reader's primary practice is GeneX Laboratories - Costa Mesa, at 3151 Airway Ave, Ste M1, Costa Mesa, CA 92626. The practice phone is (949) 610-7253.

Dr. Reader's primary practice is GeneX Laboratories - Costa Mesa in Costa Mesa, California. The medical group on file is UCLA Medical Group.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reader practices. Vendor and product names are available with a free account.

Psychiatry is Dr. Reader's primary specialty in the NPI Registry, under taxonomy code 2084P0800X. Dr. Reader is board certified in psychiatry by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Reader's licenses on file in 5 states: California, Montana, Virginia, District of Columbia and Maryland.

Dmand AI lists anxiety, bipolar disorder and schizophrenia among the conditions Dr. Reader treats.

CMS data shows 50 Medicare services from Dr. Reader across 2 procedure codes in 2021, for 15 Medicare patients. Medicare paid $3,485 for them. Every service was in an office.

CMS counts 15 Medicare patients who saw Dr. Reader in 2024. The largest group is 85 and over, with 0 patients. 75% of them have anxiety, and 75% have depression. Their average risk score is 1.84, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reader's median patient age at 18, with 37% women.

In 2024, Dr. Reader wrote 403 Medicare Part D claims for 37 patients. 93% of them were for generic drugs. CMS names the drug for 286 of them, across 14 drugs with 11 or more claims each, at $3,713 in total drug cost. In 2023, CMS named 89 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Reader for performance year 2024, reported as part of a group.

CMS Open Payments shows 45 general payments to Dr. Reader from 20 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $250.

Dr. Reader graduated from Uniformed Services University, F. Edward Hebert School of Medicine in 2005.

Dr. Reader is in network with 9 carriers, including Blue Cross Blue Shield of Michigan, Elevance and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.